LoValTech

@BPIFrance drawers pays tribute to @LoValTech with this short comics from the birth of our revolutionary vaccine within @BioMAP team to the company creation to bring the vaccine to the global population. Go to read it ! #BD #research #COVID19 #lovaltech #nasalvaccine

Covid-19 : ces signes qui annoncent l’arrivée d’une nouvelle vague ! Plusieurs variants, un seul vaccin ! #unproblèmeunesolution #besafe #vaccin #COVID19 #variant #lovaltech lexpress.fr/sciences-sante…

Patrick Barillot was invited to appear on @BFMTV's Good morning Business program to give an update on the development of the @LoValTechFR nasal vaccine. #nasalvaccine #lovaltech #COVID19 #workinprogress youtube.com/watch?v=4wE6Te…

@Patrick Barillot was invited to appear on @BFMTV's Good morning Business program to give an update on the development of the @LoValTechFR nasal vaccine #nasalvaccine #lovaltech #COVID19 #workinprogress 👉youtube.com/watch?v=4wE6Te…

‘For the first time, we could be ahead of variants’ As detailed in this Maddyness article, this is one of the major advantages of our COVID-19 vaccine. #nasalvaccine #lovatech #variants #article #DaVinciLabs #DeepTech #SynBio maddyness.com/2023/08/23/lov…

#COVID19 #vaccine #epidemic #lovatech #variants

The LoValTech vaccine targets not only the Spike protein but also the N one. The N protein does not mutate, ensuring LVT vaccine efficacy against all current and future variants.

Today, vaccines against COVID19 have limitations and are ineffective against future variants, including the Eris variant.  LoValTech wants to emphasize the importance of developing a vaccine effective against all COVID19 variants, which would avoid this kind of epidemic.

#research #article #scientific #lovaltech

Needle free vaccines start to come out from the labs!!!❌💉 Mathieu Epardaud brilliantly explains the interest of nasal vaccination ! To find out all about these French advances, don't hesitate to consult the article in Sciences & Vie n°1271 by Kheira Bettayeb 📖 #nasalvaccines

We are very proud and honored to inform you that Isabelle Dimier-Poisson has been conferred  the"Chevalier de la Légion d'Honneur" award by the French Prime Minister, Elisabeth Borne. #nomination #innovation #vaccine #lovaltech #research

✅€8.4M to develop a nasal #vaccine against #COVID19 The #startup @LoValTechFR & @aptar Pharma are winners of the French government investment plan #France2030 👏 #innovation using an INRAE & @UnivTours patent ⤵️ @EUScienceInnov @WHO

👏@LoValTechFR & @aptar Pharma sont lauréats #France2030 et recevront un financement de 8.4M€ pour développer un #vaccin contre le #Covid par voie nasale 🤝La #startup s'appuie sur un brevet INRAE & @UnivTours #InoverAvecINRAE @SGPI_avenir @Bpifrance ➡️url.inrae.fr/3KnShZx

👉 einpresswire.com/article/646272…

Thanks to the support of #france2030 steered by @BrunoBonnellOff and @GeraldineLeveau of the @SGPI_avenir and @Bpifrance, LoValTech and Aptar Pharma will be able to offer the world's population next-generation "made in France" vaccines! 🌍 #biotech #vaccine #lovaltech #France2030

LoValTech and @aptar Pharma partnership wins #france2030 program by responding to the i-Demo collaborative project call for the MUCOVAC 2.0 project, supported as part of the "Emerging Infectious Diseases and CBRN Threats" Acceleration Strategy. #biotech #vaccine #France2030

Une nouvelle nomination pour Isabelle ! Nous sommes très fiers 😌

Merci à @VivaTech pour cette superbe organisation et merci à la @RCValdeLoire pour cette incroyable opportunité 👏🏻 #Vivatechn2023 #startup #innovation #healthtech #HTD2023

Retour sur ces deux derniers jours à @VivaTech : De nombreuses rencontres intéressantes et intéressées par notre projet, 🤝 Des échanges enrichissants avec des professionnels de la Tech et de la Healthtech 🦾